Introducing Patterns of Variability for Overcoming Compensatory Adaptation of the Immune System to Immunomodulatory Agents: A Novel Method for Improving Clinical Response to Anti-TNF Therapies
Primary lack of response and secondary loss of response (LOR) are major obstacles to the use of anti–tumor necrosis factor (TNF)-based therapies in patients with rheumatoid arthritis or inflammatory bowel disease. Here, we review the mechanisms and methods for predicting LOR and the currently used m...
Main Authors: | Tawfik Khoury, Yaron Ilan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.02726/full |
Similar Items
-
The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics
by: Dan-in Jang, et al.
Published: (2021-03-01) -
Changes in the Penetration Rate of Biosimilar Infliximab Within Japan Using a Japanese Claims Database
by: Matsumoto T, et al.
Published: (2021-02-01) -
Methotrexate Enhances Apoptosis of Transmembrane TNF-Expressing Cells Treated With Anti-TNF Agents
by: Qiaolei Wang, et al.
Published: (2020-08-01) -
Immunomodulatory Effects of Dopamine in Inflammatory Diseases
by: Yifei Feng, et al.
Published: (2021-04-01) -
Molecular Basis for the Neutralization of Tumor Necrosis Factor α by Certolizumab Pegol in the Treatment of Inflammatory Autoimmune Diseases
by: Jee Un Lee, et al.
Published: (2017-01-01)